KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Other financing activities: 2015-2023

Historic Other financing activities for Travere Therapeutics (TVTX) over the last 8 years, with Dec 2023 value amounting to -$1.4 million.

  • Travere Therapeutics' Other financing activities was N/A to -$259,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.4 million, marking a year-over-year change of. This contributed to the annual value of -$1.4 million for FY2023, which is 113.99% down from last year.
  • According to the latest figures from FY2023, Travere Therapeutics' Other financing activities is -$1.4 million, which was down 113.99% from $9.9 million recorded in FY2022.
  • Travere Therapeutics' 5-year Other financing activities high stood at $9.9 million for FY2022, and its period low was -$6.1 million during FY2021.
  • For the 3-year period, Travere Therapeutics' Other financing activities averaged around $798,667, with its median value being -$1.4 million (2023).
  • Its Other financing activities has fluctuated over the past 5 years, first spiked by 261.89% in 2022, then slumped by 113.99% in 2023.
  • Over the past 4 years, Travere Therapeutics' Other financing activities (Yearly) stood at $1.8 million in 2019, then reached -$6.1 million in 2021, then surged by 261.89% to $9.9 million in 2022, then plummeted by 113.99% to -$1.4 million in 2023.